Literature DB >> 21196205

Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis.

Alan Wells1, Yvonne L Chao, Jelena Grahovac, Qian Wu, Douglas A Lauffenburger.   

Abstract

The most ominous stage of cancer progression is metastasis, or the dissemination of carcinoma cells from the primary site into distant organs. Metastases are often resistant to current extirpative therapies and even the newest biological agents cure only a small subset of patients. Therefore a greater understanding of tumor biology that integrates properties intrinsic to carcinomas with tissue environmental modulators of behavior is needed. In no aspect of tumor progression is this more evident than the acquisition of cell motility that is critical for both escape from the primary tumor and colonization. In this overview, we discuss how this behavior is modified by carcinoma cell phenotypic plasticity that is evidenced by reversible switching between epithelial and mesenchymal phenotypes. The presence or absence of intercellular adhesions mediate these switches and dictate the receptivity towards signals from the extracellular milieu. These signals, which include soluble growth factors, cytokines, and extracellular matrix embedded with matrikines and matricryptines will be discussed in depth. Finally, we will describe a new mode of discerning the balance between epithelioid and mesenchymal movement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196205      PMCID: PMC4003907          DOI: 10.2741/3722

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  223 in total

1.  The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts.

Authors:  Andreas Kouroumalis; Robert J Nibbs; Herve Aptel; Karen L Wright; George Kolios; Stephen G Ward
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

2.  Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.

Authors:  Hiroaki Kajiyama; Kiyosumi Shibata; Mikio Terauchi; Kazuhiko Ino; Akihiro Nawa; Fumitaka Kikkawa
Journal:  Int J Cancer       Date:  2008-01-01       Impact factor: 7.396

3.  Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9.

Authors:  E Mira; S Mañes; R A Lacalle; G Márquez; C Martínez-A
Journal:  Endocrinology       Date:  1999-04       Impact factor: 4.736

4.  A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.

Authors:  H Geminder; O Sagi-Assif; L Goldberg; T Meshel; G Rechavi; I P Witz; A Ben-Baruch
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

5.  Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

Authors:  Chris J Scotton; Julia L Wilson; Kate Scott; Gordon Stamp; George D Wilbanks; Simon Fricker; Gary Bridger; Frances R Balkwill
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

6.  Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes.

Authors:  K Kawada; H Hosogi; M Sonoshita; H Sakashita; T Manabe; Y Shimahara; Y Sakai; A Takabayashi; M Oshima; M M Taketo
Journal:  Oncogene       Date:  2007-02-05       Impact factor: 9.867

7.  The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.

Authors:  Lilach Goldberg-Bittman; Eran Neumark; Orit Sagi-Assif; Elina Azenshtein; Tsipi Meshel; Isaac P Witz; Adit Ben-Baruch
Journal:  Immunol Lett       Date:  2004-03-29       Impact factor: 3.685

8.  Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization.

Authors:  S Beissert; M Bergholz; I Waase; G Lepsien; A Schauer; K Pfizenmaier; M Krönke
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

9.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

10.  Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling.

Authors:  Anand Krishnan V Iyer; Kien T Tran; Linda Griffith; Alan Wells
Journal:  J Cell Physiol       Date:  2008-02       Impact factor: 6.384

View more
  37 in total

1.  Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.

Authors:  Rebecca J Burkhalter; Suzanne D Westfall; Yueying Liu; M Sharon Stack
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

2.  Liver protects metastatic prostate cancer from induced death by activating E-cadherin signaling.

Authors:  Bo Ma; Sarah E Wheeler; Amanda M Clark; Diana L Whaley; Min Yang; Alan Wells
Journal:  Hepatology       Date:  2016-09-23       Impact factor: 17.425

3.  The mitogen-activated protein (MAP) kinases p38 and extracellular signal-regulated kinase (ERK) are involved in hepatocyte-mediated phenotypic switching in prostate cancer cells.

Authors:  Bo Ma; Alan Wells
Journal:  J Biol Chem       Date:  2014-03-11       Impact factor: 5.157

4.  Expression of E-cadherin in oral lichen planus.

Authors:  Yong DU; Haobo Li
Journal:  Exp Ther Med       Date:  2015-07-23       Impact factor: 2.447

Review 5.  The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment.

Authors:  Andreas Bikfalvi; Clotilde Billottet
Journal:  Am J Physiol Cell Physiol       Date:  2020-01-08       Impact factor: 4.249

6.  Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma.

Authors:  Hong-Liang Shen; Qing-Jun Liu; Pei-Qian Yang; Ye Tian
Journal:  Tumour Biol       Date:  2014-12-21

7.  Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases.

Authors:  Yvonne Chao; Qian Wu; Marie Acquafondata; Rajiv Dhir; Alan Wells
Journal:  Cancer Microenviron       Date:  2011-09-03

8.  ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.

Authors:  Yihui Ma; Xiangyu Zheng; Jun Zhou; Ying Zhang; Kuisheng Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 9.  Targeting tumor cell motility as a strategy against invasion and metastasis.

Authors:  Alan Wells; Jelena Grahovac; Sarah Wheeler; Bo Ma; Douglas Lauffenburger
Journal:  Trends Pharmacol Sci       Date:  2013-04-06       Impact factor: 14.819

Review 10.  Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion.

Authors:  Jelena Grahovac; Alan Wells
Journal:  Lab Invest       Date:  2013-11-18       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.